Kolexia
Cayla Guillaume
Cardiologie
Hôpital Carémeau
Nîmes, France
410 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infarctus du myocarde Infarctus Infarctus du myocarde avec sus-décalage du segment ST Maladie des artères coronaires Syndrome coronarien aigu Hémorragie Thrombose Accident vasculaire cérébral Ischémie myocardique

Industries

AstraZeneca
4 collaboration(s)
Dernière en 2021
Abbott
4 collaboration(s)
Dernière en 2023
Sorin
4 collaboration(s)
Dernière en 2023
ASSOCIATION POUR LE DEVELOPPEMENT DE LA COMMUNICATION EN CARDIOLOGIE INTERVENTIONNELLE (ADCCI)
3 collaboration(s)
Dernière en 2023

Dernières activités

TARGET-FIRST: Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy
Essai Clinique (MicroPort CRM)   13 mars 2024
Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome.
JACC. Cardiovascular interventions   16 février 2024
Clinical effects of permanent pacemaker implantation after transcatheter aortic valve implantation: Insights from the nationwide FRANCE-TAVI registry.
Archives of cardiovascular diseases   13 février 2024
BEST: Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Native Aortic Valve Stenosis
Essai Clinique (CHU Lille)   09 février 2024
Long-term follow-up of balloon-expandable valves according to the implantation strategy: insight from the DIRECTAVI trial.
American heart journal   20 janvier 2024
DIRECTAVI: Implantation of the Transcatheter Aortic Prosthesis SAPIEN 3 With or Without Prior Balloon Predilatation
Essai Clinique (Edwards Lifescience)   15 janvier 2024
DIRECTAVILONG: 5 Years Hemodynamic and Clinical Follow-up of the SAPIEN 3 Transcatheter Heart Valve According to the Implantation Strategy: Insight From the Randomized DIRECTAVI Trial
Essai Clinique (CHU Montpellier)   15 janvier 2024
Flecainide to prevent atrial arrhythmia after patent foramen ovale closure Rationale and design of the randomized AFLOAT study.
European heart journal. Cardiovascular pharmacotherapy   12 janvier 2024
MATRIX-2: Monotherapy With a P2Y12 Inhibitor Followed by a Direct-acting Oral Anticoagulant in Patients With ATRial fIbrillation Undergoing suprafleX Cruz Coronary Stent Implantation
Essai Clinique (Sahajanand Medical Technologies Limited)   11 janvier 2024
De-escalation from potent P2Y12 inhibitors to clopidogrel: an alternative to short DAPT duration in HBR patients?
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology   04 décembre 2023